SATT AxLR
SATT AxLR
Governance
Services for companies
Annual reports
Assisting you
Researchers
Call-for-projects
Companies
Startups
Practical guide
Technology offerings
Invest
In our technologies
In our startups
Technologies
Startups
AxLR TV
Working with AxLR
Purchasing & public procurement
Join us
Our startups are hiring
Media
News
Agenda
Press kit
Communication kit
Contact
✕
Home
Health & Biotechnology
PERSPECTYV
0
AVAILABLE TECHNOLOGY | Facioscapulohumeral dystrophy – Personalized treatment –
RESIST-430
0
AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Gamma-peptides
CAPDCM
0
AVAILABLE TECHNOLOGY | Microfluidics – Chemoattraction – Drug release
PL-VAC
0
AVAILABLE TECHNOLOGY | Leishmanioses – Secretomes – Multi-epitope peptide vaccine
ALPHA-CENTAURI
0
AVAILABLE TECHNOLOGY | Innate immunity – Infectious diseases – Cancer
AVIITAM
7
START-UP | Telemedecine
EPIDROP
6
AVAILABLE TECHNOLOGY I Circulating tumor cells
DIAG2TEC – MYELODIAG
4
START-UP I Oncology – Therapeutic diagnostic tool
EMOSIS
6
START-UP I i Lab – Diagnostic Kit – Hemostasis
Précédent
1
2
3
4
5
Suivant